Skin Neoplasm Market: Emerging Therapies, Key Players, and Future Outlook | DelveInsight
Skin neoplasms, commonly referred to as abnormal growths of skin cells, encompass a broad range of benign and malignant tumors. Among the most prevalent malignant skin neoplasms are basal cell carcinoma (BCC) , squamous cell carcinoma (SCC) , and melanoma , with the former two classified as non-melanoma skin cancers (NMSCs). According to the American Cancer Society, skin cancer remains the most commonly diagnosed cancer in the United States, with millions of new cases annually. As the incidence continues to rise, the Skin Neoplasm Market is witnessing notable developments in diagnostics, therapeutics, and overall disease management. https://www.delveinsight.com/report-store/skin-neoplasms-market Understanding Skin Neoplasms Treatment Market Skin neoplasms may present as either non-cancerous (benign) or cancerous (malignant) lesions. While benign neoplasms such as moles and seborrheic keratoses rarely pose significant health risks, malignant neoplasms can invade nearby t...